Page 29 - Drug Controller News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India's first general robotic surgery system to hit markets in 4-6 months SS Innovations is planning to make 100 units this year of the multi arm novel 'Mantra' Surgical Robotic System indigenously developed over the last three years. Plans are to make and sell over 1,000 units within the next five years PB Jayakumar | February 26, 2021 | Updated 22:52 IST Plans are to make and sell over 1,000 units within the next five years New Delhi-based SS Innovations, promoted by renowned robotic cardiothoracic surgeon Dr Sudhir P Srivastava, will commercially launch India's first and cheapest in the w...

The city-based PNB Vesper Life Sciences has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its proprietary drug to treat the coronavirus infection and said it will soon move the government for deploying the drug for emergency use. The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support. The company on Monday said the clinical trial was initiated in November at BJ G...

Notices issued on plea saying Covishield unsafe According to the petitioner, Asif Riaz, of Anna Nagar, there was no adverse reaction in the first 10 days, but he woke up on October 11 with a severe headache. Share Via Email   |  A+A A- By Express News Service CHENNAI: The Madras High Court on Friday issued notices to the Central government and Serum Institute of India on a plea to declare the Covishield vaccine unsafe. The petitioner said he volunteered for the vaccine trial and had side effects after taking the jab. According to the petitioner, Asif Riaz, of Anna Nagar, there was no ...

Last Updated: Covid-19: Two New Vaccines Show Less Efficacy Against South African Strain Data from two new coronavirus vaccine trials have revealed that they have less efficacy in protecting the people from the new South African variant. Data from two new coronavirus vaccine trials have revealed that they have less efficacy in protecting the people from the new South African variant. The trials from Novavax and Johnson & Johnson vaccine indicated that their vaccines have less efficacy. Novavax’s trial showed the efficacy at 50 per cent, Johnson & Johnson said a single shot of its vacci...

India’s Covid-19 vaccine drive has been hampered by turnout as low as 22% in some states, as fears over the safety of the vaccine and the spread of misinformation has fuelled widespread hesitancy. On Saturday, India launched the world’s largest vaccination programme as it began the massive task of vaccinating its 1.3 billion citizens against coronavirus. On the first day of India’s vaccine drive on Saturday, more than 200,000 vaccinations were...